The United States Patent Trial and Appeal Board has handed a win to Chinese-American synthetic biologist Feng Zhang (張鋒) and his team from the Massachusetts Institute of Technology (MIT) in a dispute over patents of the gene editing technology known as CRISPR.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Society
Family of Indonesian fisher who died on Taiwan boat settles civil case
05/09/2025 08:48 PM - Society
Taiwan births hit record monthly low in April: MOI
05/09/2025 08:32 PM - Society
Cooler temperatures, heavy rain expected in Taiwan over weekend: CWA
05/09/2025 08:18 PM - Politics
Taiwan passes new law adding 4 additional national holidays
05/09/2025 08:17 PM - Culture
Famous 'meat-shaped stone' on display at new NPM exhibition in Penghu
05/09/2025 07:59 PM